A comparison of 180 degrees of treatment with diode laser trabeculoplasty in primary open-angle glaucoma and exfoliation glaucoma: A short-term study of 22 patients

Current Eye Research

Volumn 34, Issue 3, 2009, Pages 202-206

  Andreić, Veljko ^a   Miljković, Aleksandar ^a   Babić, Nikola ^a  

^a University ENT Clinic   (Serbia)

Author keywords

DLT; IOP; POAG; XFG

Indexed keywords

ADULT; ARGON LASER; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIODE LASER; EXFOLIATION SYNDROME; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; NEODYMIUM LASER; OPEN ANGLE GLAUCOMA; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRABECULOPLASTY;

AGED; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; LASERS, SEMICONDUCTOR; MALE; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 62249100595     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802680895     Document Type: Article

References (31)

1. Yanoff M. Ophthalmology 2nd ed. Mosby, St. Louis, MO, USA; 2004:1482-1499.
2. Damji KF, Shah KC, Rock WJ, et al. Selective laser trabeculoplasty vs argon laser trabeculoplasty: A prospective randomized clinical trial. Br J Ophthalmol. 1999;83:718-722.
3. Odberg T, Sandvik L. Themedium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand. 1999;77:176-181.
4. Agarwal H, Sihota R. Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients. Br J Ophthalmol. 2002;86:733-736.
5. Martinez-de-la-Casa J, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: Hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye 2004;18:498-502.
6. Shingleton BJ, Richter CU. Long-term efficacy of argon laser trabeculoplasty. Ophthalmology 1987;94:1513-1518.
7. Speath GL, Baez KA. Argon laser trabeculoplasty controls one third of progressive, uncontrolled, open angle glaucoma for 5 years. Arch Ophthalmol. 1992;110:491-494.
8. Glaucoma Laser Trial Research Group. The glaucoma laser trial (GLT) and glaucoma laser trial follow-up study. Am J Ophthalmol. 1995;120:718-731.
9. Hodge WG, Damji KF, Rock W, et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year posttreatment: Results from a randomised clinical trial. Br J Ophthalmol. 2005;89:1157-1160.
10. The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group. Ophthalmology 1990;97:1403-1413.
11. The Advanced Glaucoma Intervention Study (AGIS). 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology 1998;105:1146-1164.
12. The Early Manifest Glaucoma Trial. Factors for glaucoma progression and the effect of treatment. Arch Ophthalmol. 2003;121:48-56.
13. Odberg T, Sandvik L. Themedium and long term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand. 1999;77:176-181.
14. Weinreb RN, Crowston JG. Glaucoma Surgery: Open Angle Glaucoma. Kugler Publications: Hague, Netherlands; 2005:21-40.
15. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 2001;108:773-779.
16. Koller T, Sturmer J, Reme C, et al. Membrane formation in the chamber angle after failure of argon laser trabeculoplasty: Analysis of risk factors. Br J Ophthalmol. 2000;84:48-53.
17. Cvenkel B, Hvala A, Drnovsek-Olup B, et al. Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med. 2003;33:204-208.
18. Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol. 1999;83:29-32.
19. Hollo G. Argon and low energy, pulsed Nd:YAG laser trabeculoplasty. A prospective, comparative clinical, and morphological study. Acta Ophthalmol Scand. 1996;74:126-131.
20. Denis P. Operating principles of selective laser trabeculoplasty.
21. Alvarado JA, Latina MA, Damji KF, Katz LJ. The Science Underlying Selective Laser Trabeculoplasty. Ophthalmology Management, June 2002.
22. Latina MA, Park C. Selective targeting of trabecular meshwork alls : in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995;60:359-371.
23. Chung PY, Schuman JS, Netland PA, et al. Five-year results of a randomized, prospective, clinical trial of diode vs argon laser trabeculoplasty for open-angle glaucoma. Am J Ophthalmol. 1998;126:185-190.
24. Wise JB. Glaucoma treatment by trabecular tightening with the argon laser. Int Ophthalmol Clin. 1981;21:69-78.
25. Bylsma S, Samples J, Acott T, et al. Trabecular cell division after argon laser trabeculoplasty. Arch Ophthalmol. 1988;106:544-547.
26. European Glaucoma Society. Terminology and Guidelines for Glaucoma. DOGMA: Savona, Italy; 2nd ed. 2003.
27. Brooks AM, Gillies WE. Do any factors predict a favourable response to laser trabeculoplasty? Aust J Ophthalmol. 1984;12:149-153.
28. Traverso CE, Rolando M, Calabria G, et al. Eye parameters in-fluencing the results of argon laser trabeculoplasty in primary open-angle glaucoma. Ophthalmologica 1987;194:174-180.
29. Englert JA, Cox TA, Allingham RR, Shields MB. Argon vs diode laser trabeculoplasty. Am J Ophthalmol. 1997;124/5:627-631.
30. Johnson PB, Katz LJ, Rhee DJ. Selective laser trabeculoplasty: Predictive value of early intraocular pressure measurements for success at 3 months. Br J Ophthalmol. 2006;90:741-743.
31. Damji KF, Bowel AM, Hodge WG. Selective laser trabeculoplasty. Areview and comparison to argon laser trabeculoplasty. Ophthalmic Practice 2003;21:54-58.